
Bernadette Marquez-Nostra
University of Alabama at Birmingham, Department of Radiology
Dr. Bernadette Marquez-Nostra is an associate professor in the Division of Advanced Medical Imaging Research within the Department of Radiology and the Department of Biomedical Engineering at the University of Alabama at Birmingham. She earned her B.S. in Biochemistry from California State University-Fullerton in 2005 and her Ph.D. in Chemistry from the University of California-Davis in 2011, under the mentorship of Prof. Claude Meares. She then underwent postdoctoral training at Washington University in St. Louis from 2012 to 2017 and at the University of Alabama at Birmingham in 2017, working with Prof. Suzanne Lapi. She subsequently joined the faculty at the Yale PET Center as an assistant professor, where she established a cancer imaging laboratory from 2017 to 2023. Dr. Marquez-Nostra then relocated to the University of Alabama at Birmingham to further her research in developing nuclear imaging agents for predicting and monitoring responses to cancer therapies.

Monica Shokeen
Washington University School of Medicine, Mallinckrodt Institute of Radiology
Dr. Monica Shokeen is an associate professor of radiology at the Mallinckrodt Institute of Radiology (MIR), Washington University School of Medicine. Dr. Shokeen received her BSc in Chemistry Honors from the University of Delhi, India; her MBA from Kurukshetra University, India; and her Ph.D. in Chemistry from Washington University in Saint Louis. She completed her postdoctoral training in nanomedicine and radiochemistry at the Washington University School of Medicine. She joined the Mallinckrodt Institute of Radiology, Washington University School of Medicine as an assistant professor on tenure track in 2014.Dr. Shokeen’s laboratory investigates the biology of bone-damaging cancers such as multiple myeloma. Her lab designs molecules and employs molecularly targeted imaging approaches across modalities to evaluate disease pathogenesis. Dr. Shokeen directs the Molecular Imaging Center and is the vice chair of Diversity, Equity, Inclusion, and Justice at MIR. She is a prolific educator, course director, and inductee of the Academy of Educators. She serves on several institutional leadership committees and national and international review panels.
Radiochemistry and the development of novel radiopharmaceuticals constitute the core of nuclear medicine for imaging and cancer therapy. It is an exciting era for research in these domains as we broaden our capabilities in noninvasive imaging and radiopharmaceutical therapy. This Methods Collection includes robust techniques in radiochemistry, probe development, multi-modal imaging, image analysis, and biochemical validations of radiopharmaceuticals, along with tips and tricks to advance promising radiopharmaceuticals closer to clinical translation.
0 Views
•
Cited by 1
•
2025
•
Preclinical Sequential Dual-Tracer PET: Acquisition and Analysis
Andrew Burns1,
Ameer Mansur2,
Carlos Gallegos2,
Volkan Tekin3,
Patrick Song4,
Suzanne Lapi5,
Anna Sorace*6
1University of Alabama at Birmingham, Department of Biomedical Engineering,
2University of Alabama at Birmingham, Departments of Biomedical Engineering, Radiology,
3University of Alabama at Birmingham, Department of Radiology,
4University of Alabama at Birmingham, Graduate Biomedical Sciences ,
5University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Departments of Chemistry, Radiology,
6University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Departments of Biomedical Engineering, Radiology